PCM
CLCD

Prelude Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Prelude Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,318
Closed -$121K – 1971
2016
Q4 		$121K Buy
3,318
+2,908
+709% +$103K 0.01% 762
2016
Q3 		$16K Buy
+410
New +$6.06K ﹤0.01% 1373

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Prelude Capital Management's CLCD Position: Q1 2017 in Review

Prelude Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 3,318 shares — an estimated $121K sold.

Prelude Capital Management first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $121K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Prelude Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Prelude Capital Management sold 3,318 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $121K.
  • Prelude Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Prelude Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $121K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.